Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Academic Discovery Workshop

Academic Discovery Workshop

Tuesday, 23 September 2014 - Thursday, 25 September 2014

Conference Chair

Hakim Djaballah

Hakim Djaballah
CEO, Institute Pasteur - Korea

The drug discovery landscape is facing many challenges and changes fueled in part with the ongoing de-risking efforts by the Pharma industry; seemingly downsizing their footprint or exiting the space all together. The emerging new paradigm seems to be revolving around academic and non-for-profit institutions to carry out the discovery part of the process across a multitude of therapeutic areas. What has started as a successful interactive workshop for academic screening for the past three years, has now evolved to encompass all discovery aspects from technology development, hit identification, to licensing deals.

This new format will continue to provide delegates the opportunity to learn as well as share experiences about enabling technologies, hit to lead generation, dealing with academic tech transfer offices, identifying and working with CROs, and interrogating the value proposition of functional genomics in translational research. Organised by Dr Hakim Djaballah, Director of the HTS Core Facility at Memorial Sloan Kettering Cancer Center, our 4th Annual Academic Discovery Workshop will take place at the Sheraton Baltimore North in Baltimore from September 23rd-25th. Whether delegates are looking to expand their knowledge, engage in discussions with thought leaders during the afternoon panel discussion sessions, or simply requiring more of an insight to aid and foster future collaborations, this workshop, together with the newly established short courses is highly recommended to anyone working or has an interest in drug discovery from academia, research institutes, biotech, and Pharma companies.

The workshop also aims to help energize the discovery paradigm through open panel discussions on highly provocative topics such as “Target-based versus phenotypic-based drug discovery”, “Functional genomics technologies and their impact of target identification”, or "private-public partnerships". It is hoped that through these kind of open discussions, delegates will have the opportunity to build their own consensus and bring their points of view across. We are always seeking new ideas and inputs to help discover novel or repurpose known drugs to fight disease whether in a pharmaceutical or academic setting.

We look forward to welcoming you to our 4th Annual Academic Discovery Workshop in Baltimore and we hope the three days will be both enjoyable and informative.

Agenda Topics

  • Academic Technology Transfer: Due Diligence, Development and Commercialisation
  • Building and Financing Drug Discovery Efforts in Academia
  • Functional Genomics Technologies in 2014
  • Identifying and Working with CRO's
  • Novel and Enabling Screening Technologies in 2014
  • Public - Private Partnerships
  • RNAi and Genome Editing Technologies
  • Target versus Phenotypic Based Discovery
  • Vendor/User Perspectives on HCA in 2014

Sponsorship and Exhibition Opportunities

Exhibition Team,
+44(0)1787 315110

Confirmed Participants to date

Litao Zhang, Vice President, Leads Discovery & Optimization, Bristol-Myers Squibb
Yuhong Du, Assistant Professor and Associate Director, Emory University
Richard Neubig, Professor and Chair, Michigan State University
Tim Hammonds, Deputy Director Drug Discovery, Cancer Research Technology, UK
Haian Fu, Professor and Director, Emory University
Terry Riss, Senior Project Manager, Promega
David Shum, Assay Development Specialist, Memorial Sloan-Kettering Cancer Center
Geoffrey Bartholomeusz, Assistant Professor, MD Anderson Cancer Center
Thierry Langer, CEO, Prestwick Chemical
Chris Porter, Assistant Professor / Pediatrics, University of Colorado School of Medicine
Scott Martin, Group Leader, RNAi Screening, NCATS, NIH
Kamyar Hadian, Head, Helmholtz Zentrum München
Roland Wolkowicz, Associate Professor, San Diego State University
Bhavneet Bhinder, Bioinformatics Engineer, Memorial Sloan Kettering Cancer Center
Iain Fraser, Head Laboratory of Systems Biology, National Institutes of Health
Steve Titus, Field Application Scientist, GE Healthcare
Chi Yun, Director RNAi Core, NYU School of Medicine
Anka Ehrhardt, Director Clinical Flow Cytometry, Bristol-Myers Squibb
Jean-Philippe Stephan, Senior Scientist, Genentech
Jeanne Farrell, Business Development Director, Ichan School of Medicine
Nitin Puri, Associate Director, Product Management, Life Technologies
Rick Cope, Regional Sales Manager, SensíQ Technologies Inc.
Ann Hoffman, Investigator, GSK
Arumugham Raghunathan, Head of Business Development, Horizon Discovery Limited
Viviane Martin, Associate Director, Penn State Hershey Medical Center
Christine Brideau, Vice President of In Vitro Biology, WuXi
Madhu-Lal Nag, Research Scientist, NCATS, NIH
Chris Willis, Solution Scientist, Thomson Reuters
Susan Dilorio, , Qiagen
Charles Sacco, Entrepreneur in Residence and Director of External Relations, Drexel University

Exhibition Sponsors Media Sponsors Networking

    Keep me updated Select Bio Blog Linked in Twitter Technology Networks ePosters